Interleukin-17 (IL-17) expression is reduced during acute myocardial infarction: Role on chemokine receptor expression in monocytes and their in vitro chemotaxis towards chemokines

Toxins

Volumn 4, Issue 12, 2012, Pages 1427-1439

  Troitskaya, Maria ^a   Baysa, Anton ^a   Vaage, Jarle ^b   Sand, Kristin L ^a   Maghazachi, Azzam A ^a   Valen, Guro ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chemokine receptors; Chemokines; IL 17; Monocytes; Myocardial infarction

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR; INTERLEUKIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDITIS; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; IN VITRO STUDY; MALE; MIGRATION INHIBITION; MONOCYTE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SPLEEN CELL;

ANIMALS; CHEMOKINES; CHEMOTAXIS; INTERLEUKIN-17; INTERLEUKINS; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; MYOCARDIAL INFARCTION; RECEPTORS, CCR2; RECEPTORS, CXCR4; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-17; SPLEEN;

MUS;

EID: 84870729112     PISSN: 20726651     EISSN: None     Source Type: Journal    
DOI: 10.3390/toxins4121427     Document Type: Article

References (28)

1. Valen, G.; Yan, Z.-Q.; Hansson, G.K. Nuclear factor κ-B and the heart. J. Am. Coll. Cardiol. 2001, 38, 307-314.
2. Maugeri, N.; Rovere-Querini, P.; Evangelista, V.; Godino, C.; Demetrio, M.; Baldini M.; Figini, F.; Coppi, G.; Slavich, M.; Camera, M.; et al. An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes. PLoS One 2012, 7, e39484
3. Klingenberg, R.; Luscher, T.F. Inflammation in coronary artery disease and acute myocardial infarction-Is the stage set for novel therapies? Curr. Pharm. Des. 2012, 18, 4358-4369.
4. Hansson, G.K.; Klareskog, L. Pulling down the plug on atherosclerosis: Cooling down the inflammasome. Nat. Med. 2011, 17, 790-791.
5. Imanishi, T.; Akasaka T. Biomarkers associated with vulnerable atheromatous plaque. Curr. Med. Chem. 2012, 19, 2588-2596.
6. Breland, U.M.; Hollan, I.; Saatvedt, K.; Almdahl, S.M.; Damås, J.K.; Yndestad, A.; Mikkelsen, K.; Førre, O.T.; Aukrust, P.; Ueland, T. Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease. Rheumatology 2010, 49, 1118-1127.
7. Eyerich, S.; Eyerich, K.; Cavani, A.; Schmidt-Weber, C. IL-17 and IL-22: Siblings, not twins. Trends Immunol. 2010, 31, 354-361.
8. Duhen, T.; Geiger, R.; Jarrossay, D.; Lanzavecchia, A.; Sallusto, F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009, 10, 857-863.
9. Simon, T.; Taleb, S.; Danchin, N.; Laurans, L.; Rousseau, B.; Cattan, S.; Montely, J.M.; Dubourg, O.; Tedgui, A.; Kotti, S.; Mallat, Z. Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. Eur. Heart J. 2012, doi:10.1093/eurheartj/ehs263
10. Barry, S.P.; Ounzain, S.; McGormick, J.; Scarabelli, T.M.; Chen-Scarabelli, C.; Saravolatz, L.; Faggian, G.; Mazzucco, A.; Suzuki, H.; Thiemermenn, C.; et al. Enhanced IL-17 signaling following myocardial ischemia-reperfusion. Int. J. Cardiol. 2011, doi:10.1016/j.ijcard.2011.08.849
11. Annunziato, F.; Cosmi, L.; Liotta, F.; Maggi, E.; Romagnani, S. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int. Immunol. 2008, 20, 1361-1368.
12. Pandya, A.D.; Al-Jaderi, Z.; Høglund, R.A.; Holmøy, T.; Harbo, H.F.; Norgauer, J.; Maghazachi, A.A. Identification of human NK17/NK1 cells. PLoS One 2011, 6, e26780.
13. Cella, M.; Fuchs, A.; Vermi, W.; Facchetti, F.; Otero, K.; Lennerz, J.K.; Doherty, J.M.; Mills, J.C.; Colonna, M. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457, 722-725.
14. Hwang, S.Y.; Kim, J.Y.; Kim, K.W.; Park, M.K.; Moon, Y.; Kim, W.U.; Kim, H.Y. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- andPI3-kinase/Akt-dependent pathways. Arthritis Res. Ther. 2004, 6, R120-R128.
15. Sylvester, J.; Liacini, A.; Li, W.Q.; Zafarullah, M. Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes. Cell. Signal. 2004, 16, 469-476.
16. Honorati, M.C.; Neri, S.; Cattini, L.; Facchini, A. Interleukin-17 a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis Cartilage 2006, 14, 345-352.
17. Komiyama, Y.; Nakae, S.; Matsuki, T.; Nambu, A.; Ishigame, H.; Kakuta, S.; Sudo, K.; Iwakura, Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177, 566-573.
18. Lubberts, E.; Koenders, M.I.; Oppers-Walgreen, B.; van den Bersselaar, L.; Coenen-de Roo, C.J.; Joosten, L.A.; van den Berg, W.B. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004, 50, 650-659.
19. van der Fits, L.; Mourits, S.; Voerman, J.S.; Kant, M.; Boon, L.; Laman, J.D.; Cornelissen, F.; Mus, A.M.; Florencia, E.; Prens, E.P.; Lubberts, E. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 2009, 182, 5836-5845.
20. Silverpil, E.; Linden, A. IL-17 in human asthma. Expert Rev. Respir. Med. 2012, 6, 173-186.
21. Li, L.; Huang, L.; Vergis, A.L.; Ye, H.; Bajwa, A.; Narayan, V.; Strieter, R.M.; Rosin, D.L.; Okusa, M.D. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 2010, 120, 331-342.
22. Akamatsu, Y.; Yamamoto, T.; Yamamoto, K.; Oseko, F.; Kanamura, N.; Imanishi, J.; Kita, M. Porphyromonas gingivalis induces myocarditis and/or myocardial infarction in mice and IL-17A is involved in pathogenesis of these diseases. Arch. Oral Biol. 2011, 56, 1290-1298.
23. Lusis, A.J. Atherosclerosis. Nature 2000, 407, 233-241.
24. Proulx, C.; El-Helou, V.; Gosselin, H.; Clement, R.; Gillis, M.A.; Villeneuve, L.; Calderone, A. Antagonism of stromal cell-derived factor-1α reduces infarct size and improves ventricular function after myocardial infarction. Pflugers Arch. 2007, 455, 241-250.
25. Liehn, E.A.; Tuchscheerer, N.; Kanzler, I.; Drechsler, M.; Fraemohs, L.; Schuh, A.; Koenen, R.R.; Zander, S.; Soehnlein, O.; Hristov, M.; et al. Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J. Am. Coll. Cardiol. 2011, 58, 2415-2423.
26. Taleb, S.; Romain, M.; Ramkhelawon, B.; Uyttenhove, C.; Pasterkamp, G.; Herbin, O.; Esposito, B.; Perez, N.; Yasukawa, H.; van Snick, J.; et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 2009, 206, 2067-2077.
27. O'Connor, W.; Kamanaka, M.; Booth, C.J.; Town, T.; Nakae, S.; Iwakura, Y.; Kolls, J.K.; Flavell, R.A. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 2009, 10, 603-609.
28. Czibik, G.; Gravning, J.; Martinov, V.; Ishaq, B.; Attramadal, H.; Valen, G. Remote delivery of DNA encoding for hypoxia-inducible factor 1 alpha is protective against in vivo myocardial ischemia-reperfusion injury. Life Sci. 2011, 16, 71-78.